ACET: Adicet O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
Adicet Bio sinovlar va vektorlarni yaratish uchun tashqi pudratchilarga tayanadi. Kompaniyaning narx-o'sish nisbati ushbu jarayon dinamikasini vizuallashtiradi, bunda 0.00 ko'rsatkichning joriy qiymatini aks ettiradi. Daromadlar tibbiyot markazlariga allogeneik T-hujayralarni yetkazib berishga asoslangan, pipeline risklari esa global sog'liqni saqlash gigantlari bilan hamkorlik orqali minimallashtirilgan.
Adicet Bio (ACET) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- kompaniyaning balans qiymati tafsilotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati Adicet Bio|ACET - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi adicetbio.com|ACET - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Adicet|ACET - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzlari Adicet Bio|Shoshilinch likvidlik koeffitsiyenti adicetbio.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
ACET - Sof foyda|Kompaniya foydasi prognozi Adicet Bio|ACET - P/E multiplikatori|Prognoz qilingan narxning foydaga nisbati adicetbio.com|ACET - PEG multiplikatori|Kompaniya qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Adicet|ACET - Eskirish chegirilmasdan oldingi operatsion foyda|So'nggi to'rtta chorak uchun bir aksiya uchun foyda Adicet Bio|ACET - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi adicetbio.com|ACET - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi Adicet Bio
Kompaniyaning umumiy tahlili:ACET - Adicet Bio Inc.
Adicet Bio an'anaviy bozor raqobatidan chetlab o'tish uchun innovatsion gamma-delta T-hujayra terapiyalarini ishlab chiqishga e'tibor qaratadi. Kompaniyaning narxning o'sishga nisbati dinamikasi ushbu ishlanmalarning investitsiya samaradorligini aks ettiradi. Ushbu metrika P/E nisbatini kutilayotgan foyda o'sishi bilan solishtirib, aktivning qadrsizlanganini ochib beradi. Bir birlikdan past qiymat yuqori kapitalizatsiya salohiyatidan dalolat beradi. Ushbu ko'rsatkich intensiv klinik poygalar davrida biznesning istiqbollarini aniqlashga yordam beradi.
Raqobatdosh kompaniyalar
ARGX (argenx N.V.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori BNTX (BioNTech Group)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Abivax (ABVX)|ADMA - Narxning foydaga va o‘sish sur’atiga nisbati|protagonist-inc.com (PTGX) - Narx-foyda va o‘sish multiplikatori|Immunovant (IMVT) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Kiniksa Pharmaceuticals, Ltd.|Narx-foyda va o‘sish multiplikatori GRFS|PEG multiplikatori Adaptive Biotechnologies Inc.|Narxning foydaga va o‘sish sur’atiga nisbati Celldex Therapeutics (CLDX)|auriniapharma.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori BCRX (BioCryst Pharmaceuticals)|Vera Therapeutics Inc (VERA) - O‘sish sur’atiga tuzatilgan narx-foyda|Dianthus Pharma - PEG multiplikatori|PHVS - PEG multiplikatori|ABCL: PEG multiplikatori|O‘sishni hisobga olgan narx-foyda koeffitsiyenti TRML|PGEN (Precigen) - PEG multiplikatori|Pharming Group NV (PHAR) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|PEG multiplikatori NKTR|Narx-foyda va o‘sish multiplikatori Upstream Pharma UPB|PEG multiplikatori ZBIO (Zenas Biopharma Inc)|immunome.com (IMNM) - O‘sish sur’atiga tuzatilgan narx-foyda|GOSS: Narx-foyda va o‘sish multiplikatori|KalVista Pharma - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|SEPN (Septerna Corp) - Narx-foyda va o‘sish multiplikatori|Pieris Corp - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|SVRA (Savara Inc.) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati RIGL|PEG multiplikatori ANAB|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Astria Therapeutics Inc|Narxning foydaga va o‘sish sur’atiga nisbati enGene Bio ENGN|rapt.com (RAPT) - O‘sish sur’atiga tuzatilgan narx-foyda|Aerovate - PEG multiplikatori|ACRS - PEG multiplikatori|KYTX: PEG multiplikatori|Narx-foyda va o‘sish multiplikatori Tiziana Life Sciences Ltd.|CABA (Cabaletta Bio, Inc) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Ventyx Biosciences, Inc VTYX|Narx-foyda va o‘sish multiplikatori THTX (Theratechnologies Inc.)|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati AVTX|Narxning foydaga va o‘sish sur’atiga nisbati Eledon Pharmaceuticals, Inc. ELDN|AGEN (Agenus, Inc.) - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|Climb Bio, Inc. - PEG multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ZURA (zurabio.com)|ATYR: PEG multiplikatori|Adagene Inc. (ADAG) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati ImageneBio|STTK: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Equillium, Inc. (EQ)|Narx-foyda va o‘sish multiplikatori connectbiopharm.com CNTB|PEG multiplikatori IMUX (Immunic)|PEG multiplikatori Atara Biotherapeutics, Inc. ATRA|IFRX: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti XFOR (X4 Pharmaceuticals Inc.)|CELU: PEG multiplikatori|INMB - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Barinthus Biotherapeutics|Narx-foyda va o‘sish multiplikatori kezarlifesciences.com (KZR)|Narxning foydaga va o‘sish sur’atiga nisbati SAB Biotherapeutics, Inc. (SABS)|Narx-foyda va o‘sish multiplikatori Akari Therapeutics PLC AKTX|Enlivex Therapeutics Ltd. - Narx-foyda va o‘sish multiplikatori|PEG multiplikatori Q32 Bio Inc QTTB|GOVX - Narxning foydaga va o‘sish sur’atiga nisbati|EDSA (edesabiotech.com) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|IBIO: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Carisma Therapeutics Inc. (CARM)|XTLB (XTL Biopharmaceuticals, Ltd.) - PEG multiplikatori|PEG multiplikatori Bolt Bio|PEG multiplikatori HCWB|aptevotherapeutics.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori AIM (AIM ImmunoTech)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Aditxt Inc. (ADTX)|GRI Bio Corp - PEG multiplikatori|XORTX Corp (XRTX) - Narx-foyda va o‘sish multiplikatori|HIND: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda revbiosciences.com (REVB)|Narx-foyda va o‘sish multiplikatori INDP|SCNI (Scinai Immunotherapeutics Ltd) - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori CALI (CalciMedica, Inc.)|AFMD (affimed.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori ALLK (Allakos)|HOOKIPA Pharma, Inc. - Narxning foydaga va o‘sish sur’atiga nisbati|IGM Bio - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati iTeos Therapeutics Inc ITOS|Ocean Bio (OCEA) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda TC BioPharm Ltd (TCBP)|THRD (Third Harmonic Bio) - PEG multiplikatori
